Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myel (Q38801429)
Jump to navigation
Jump to search
scientific article published on 20 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myel |
scientific article published on 20 January 2016 |
Statements
1 reference
Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myel (English)
1 reference
Cheng Chen
1 reference
Xiaofei Liang
1 reference
Xiaochuan Liu
1 reference
Beilei Wang
1 reference
Fengming Zou
1 reference
Aoli Wang
1 reference
Shuang Qi
1 reference
Zheng Zhao
1 reference
Wenchao Wang
1 reference
Ziping Qi
1 reference
Fengchao Lv
1 reference
Zhenquan Hu
1 reference
Li Wang
1 reference
Shanchun Zhang
1 reference
Qingsong Liu
1 reference
Jing Liu
1 reference
20 January 2016
1 reference
1 reference
Identifiers
1 reference